Yes, TDP-43 can serve as a biomarker for certain neurodegenerative diseases. The presence of TDP-43 inclusions in tissue biopsies can aid in the diagnosis of ALS and FTLD. Moreover, ongoing research aims to identify TDP-43 levels in cerebrospinal fluid (CSF) and blood as potential non-invasive biomarkers for early disease detection and monitoring.
